Omnipod 5 DEXG7G6 pods (GEN 5) 5S
Ended Awarded Last action
- Contract number
- SPE2DR26F3P5Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,130
Award facts
- Contract value 100% obligated
- $31,129.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at approximately $31.1K by the Defense Logistics Agency (DLA) on January 21, 2026, for the supply of Omnipod 5 Dexcom G7 Generation 5 insulin infusion pods. The award represents a firm fixed-price contract with no set-aside designation, indicating competitive procurement, and is scheduled for completion by January 22, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.9 million through December 2026. This comprehensive IDC vehicle enables AmerisourceBergen to supply a broad spectrum of pharmaceutical products and medical supplies to support military healthcare systems globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA, a defense agency within the Department of Defense, manages the Medical Supply Chain to ensure adequate pharmaceutical and medical commodity distribution to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F3P5Q?
SPE2DR26F3P5Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F3P5Q worth?
The government has obligated $31,130 on SPE2DR26F3P5Q.
Is contract SPE2DR26F3P5Q an order under another contract?
Yes. SPE2DR26F3P5Q is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3P5Q competed?
The extent of competition for SPE2DR26F3P5Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award